Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25031 | 22228717 | Diabetes | TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice. | 2012 | Details |
| A25037 | 22227046 | Arch Med Res | Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease. | 2012 | Details |
| A25038 | 22224077 | Hepat Mon | Obesity and air pollution: global risk factors for pediatric non-alcoholic fatty liver disease. | 2011 | Details |
| A25040 | 22221818 | Liver Int | The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. | 2011 | Details |
| A25044 | 22221215 | Nutr Rev | Therapeutic potential of green tea in nonalcoholic fatty liver disease. | 2012 | Details |
| A25045 | 22219597 | World J Gastroenterol | Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. | 2011 | Details |
| A25048 | 22215535 | IUBMB Life | Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptor. | 2012 | Details |
| A25051 | 22213086 | Hepatology | Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. | 2012 | Details |
| A25056 | 33907358 | J Proteomics Bioinform | High Fat Diet-Induced Changes in Hepatic Protein Abundance in Mice. | 2012 | Details |
| A25061 | 24713801 | Ann Gastroenterol | Non-alcoholic fatty liver disease may develop in individuals with normal body mass index. | 2012 | Details |
| A25062 | 24436572 | Curr Trends Endocinol | Fatty acid metabolism and thyroid hormones. | 2012 | Details |
| A25066 | 23750438 | Przegl Lek | [Nonalcoholic fatty liver disease as a risk factor of macroangiopahty in patients with type 2 diabetes]. | 2012 | Details |
| A25067 | 22201932 | Front Biosci (Elite Ed) | Influence of lifestyle habits, nutritional status and insulin resistance in NAFLD. | 2012 | Details |
| A25070 | 22197629 | Dig Liver Dis | Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis. | 2011 | Details |
| A25071 | 22196506 | J Acupunct Meridian Stud | Ayurvedic formulation of Liv-Pro-08 reduces nonalcoholic fatty liver disease in rats fed with high-fat diet. | 2011 | Details |
| A25072 | 22194737 | Exp Diabetes Res | The role of metformin in the management of NAFLD. | 2011 | Details |
| A25073 | 22190925 | Int J Endocrinol | Intrauterine growth retardation and nonalcoholic Fatty liver disease in children. | 2011 | Details |
| A25075 | 22189171 | Diabetes Res Clin Pract | Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease? | 2011 | Details |
| A25078 | 22187656 | J Lipids | Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target. | 2011 | Details |
| A25082 | 22183953 | Hepatology | Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats. | 2012 | Details |
| A25085 | 22183820 | Dig Dis Sci | Prevalence of hypothyroidism in nonalcoholic fatty liver disease. | 2011 | Details |
| A25086 | 22183689 | Hepatology | Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A25087 | 22183113 | Curr Opin Infect Dis | From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management. | 2012 | Details |
| A25090 | 22181832 | Intern Med J | Relationship between non-alcoholic fatty liver disease and pulmonary function. | 2012 | Details |
| A25093 | 22179204 | Mol Med Rep | Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism. | 2011 | Details |
| A25094 | 22176347 | Hepatol Res | High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism. | 2011 | Details |
| A25097 | 22173246 | Singapore Med J | Metabolic syndrome. | 2011 | Details |
| A25101 | 22170794 | Eur J Endocrinol | Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. | 2011 | Details |
| A25103 | 22168074 | Eksp Klin Gastroenterol | [Elastography efficiency in the liver fibrosis determination in patients with nonalcoholic fatty liver disease]. | 2011 | Details |
| A25109 | 22166563 | Ann Hepatol | Serum homocysteine levels in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A25133 | 22152320 | Zhonghua Gan Zang Bing Za Zhi | [Effects of telmisartan on nonalcoholic steatohepatitis rat model by activating peroxisome proliferator-activated receptor r]. | 2011 | Details |
| A25134 | 22152305 | Cell Metab | Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. | 2011 | Details |
| A25139 | 22149546 | Diabetes Technol Ther | Inflammatory markers in relation to nonalcoholic fatty liver disease in urban South Indians. | 2011 | Details |
| A25140 | 22147010 | Endocrinology | Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance. | 2011 | Details |
| A25153 | 22132232 | PLoS One | Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cells. | 2011 | Details |
| A25157 | 22126026 | Adv Clin Chem | Iron overload in nonalcoholic steatohepatitis. | 2011 | Details |
| A25159 | 22125617 | PLoS One | Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates. | 2011 | Details |
| A25161 | 22122481 | Curr Pharm Biotechnol | Non-alcoholic steatohepatitis: new insights from OMICS studies. | 2012 | Details |
| A25170 | 22117531 | Aliment Pharmacol Ther | Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25178 | 22110478 | Exp Diabetes Res | Role of transcription factor modifications in the pathogenesis of insulin resistance. | 2011 | Details |
| A25185 | 22108448 | Am J Gastroenterol | Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. | 2011 | Details |
| A25192 | 22103042 | Acta Gastroenterol Belg | Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease. | 2011 | Details |
| A25197 | 22098614 | Liver Int | Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients. | 2011 | Details |
| A25203 | 22096112 | Eur J Endocrinol | Recent advances in cardiovascular aspects of polycystic ovary syndrome. | 2011 | Details |
| A25205 | 22095588 | Hepatology | Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease. | 2012 | Details |
| A25208 | 22093607 | Gastroenterol Hepatol | Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review. | 2011 | Details |
| A25221 | 22082482 | Curr Mol Med | The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease. | 2012 | Details |
| A25226 | 22081615 | J Am Coll Nutr | Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease. | 2011 | Details |
| A25230 | 22074433 | Curr Pharm Des | Liver enzymes: potential cardiovascular risk markers? | 2011 | Details |
| A25236 | 22064361 | Free Radic Biol Med | Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. | 2011 | Details |
| A25237 | 22064320 | Lab Invest | A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein. | 2011 | Details |
| A25238 | 22059955 | Health Technol Assess | Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. | 2011 | Details |
| A25240 | 22059109 | World J Hepatol | Role of ezetimibe in non-alcoholic fatty liver disease. | 2011 | Details |
| A25252 | 22043839 | Expert Opin Pharmacother | Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome. | 2011 | Details |
| A25253 | 22043827 | Expert Opin Pharmacother | Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions. | 2011 | Details |
| A25255 | 22030814 | Acta Cir Bras | Fructose and NAFLD: metabolic implications and models of induction in rats. | 2011 | Details |
| A25261 | 22027586 | J Hepatol | Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans. | 2011 | Details |
| A25270 | 22023985 | J Hepatol | Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2011 | Details |
| A25272 | 22020821 | Hepatol Int | Non-alcoholic fatty liver disease: is iron relevant? | 2011 | Details |
| A25275 | 22015962 | J Hepatol | A lipid to treat non-alcoholic fatty liver disease - the dawn of 'lipo-rehabilitation'? | 2011 | Details |
| A25277 | 22014765 | Diabetes Res Clin Pract | Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis C. | 2011 | Details |
| A25283 | 22008843 | Food Funct | The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. | 2011 | Details |
| A25284 | 22002020 | Curr Opin Lipidol | Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic. | 2011 | Details |
| A25286 | 21999238 | J Agric Food Chem | Inhibitory effect of blueberry polyphenolic compounds on oleic acid-induced hepatic steatosis in vitro. | 2011 | Details |
| A25287 | 21994008 | Hepatology | Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. | 2012 | Details |
| A25291 | 21990946 | World J Gastroenterol | Betaine and nonalcoholic steatohepatitis: back to the future? | 2011 | Details |
| A25292 | 21989716 | Mol Cell Biochem | Ω3-Polyunsaturated fatty acids prevent lipoperoxidation, modulate antioxidant enzymes, and reduce lipid content but do not alter glycogen metabolism in the livers of diabetic rats fed on a high fat thermolyzed diet. | 2011 | Details |
| A25294 | 21987620 | World J Gastroenterol | JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. | 2011 | Details |
| A25296 | 21987488 | Hepatology | Ethnicity and nonalcoholic fatty liver disease. | 2012 | Details |
| A25297 | 21987293 | Hepatology | Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. | 2011 | Details |
| A25300 | 21986524 | Biochem Biophys Res Commun | High fat diet induced downregulation of microRNA-467b increased lipoprotein lipase in hepatic steatosis. | 2011 | Details |
| A25305 | 21983273 | Biochim Biophys Acta | Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice. | 2011 | Details |
| A25312 | 21967816 | Am J Pathol | Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in A×B mice. | 2011 | Details |
| A25315 | 21963564 | Biochim Biophys Acta | Liver triacylglycerol lipases. | 2011 | Details |
| A25316 | 21963507 | Biol Pharm Bull | meso-Dihydroguaiaretic acid inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in human HepG2 cells. | 2011 | Details |
| A25317 | 21962038 | BMC Public Health | Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. | 2011 | Details |
| A25325 | 21954411 | World J Hepatol | Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis. | 2011 | Details |
| A25328 | 21953137 | Dig Dis Sci | Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. | 2011 | Details |
| A25334 | 21951869 | Hepatol Res | Clinicopathological features of non-alcoholic fatty liver disease. | 2011 | Details |
| A25338 | 21948338 | Dig Dis Sci | Activation of liver X receptors attenuates endotoxin-induced liver injury in mice with nonalcoholic fatty liver disease. | 2011 | Details |
| A25345 | 21943357 | Nutr Metab (Lond) | The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease (NAFLD) in rats. | 2011 | Details |
| A25358 | 21930939 | Proc Natl Acad Sci U S A | Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. | 2011 | Details |
| A25360 | 21929649 | J Gastroenterol Hepatol | Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. | 2012 | Details |
| A25363 | 21918648 | Curr Gerontol Geriatr Res | Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly. | 2011 | Details |
| A25365 | 21905818 | Int J Pediatr Obes | Fatty liver disease in obese children--relation to other metabolic risk factors. | 2011 | Details |
| A25366 | 21915061 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. | 2011 | Details |
| A25367 | 21913918 | Eur J Clin Invest | Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome. | 2011 | Details |
| A25368 | 21912741 | J Nutr Metab | Putative factors that may modulate the effect of exercise on liver fat: insights from animal studies. | 2011 | Details |
| A25369 | 21912450 | World J Gastroenterol | Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. | 2011 | Details |
| A25370 | 21912108 | Ann Nutr Metab | Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome. | 2011 | Details |
| A25374 | 21910085 | Adv Exp Med Biol | Glycosphingolipids and insulin resistance. | 2011 | Details |
| A25376 | 21910083 | Adv Exp Med Biol | Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity. | 2011 | Details |
| A25380 | 21906580 | Am J Pathol | Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis. | 2011 | Details |
| A25385 | 21901256 | Dig Dis Sci | Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. | 2011 | Details |
| A25386 | 21901160 | PLoS One | Maternal obesity during gestation impairs fatty acid oxidation and mitochondrial SIRT3 expression in rat offspring at weaning. | 2011 | Details |
| A25387 | 21898634 | Ultrasound Obstet Gynecol | Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome. | 2012 | Details |
| A25392 | 21894514 | Endocrine | Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments. | 2011 | Details |
| A25395 | 21894008 | Dig Dis | Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis. | 2011 | Details |
| A25396 | 21893698 | J Physiol Pharmacol | The common adiponutrin variant p.I148M does not confer gallstone risk but affects fasting glucose and triglyceride levels. | 2011 | Details |
| A25398 | 21892559 | Nutr Hosp | Molecular mechanisms of steatosis in nonalcoholic fatty liver disease. | 2012 | Details |